Pharmena S.A. (PHR.WA)

PLN 4.0

(-3.15%)

Market Cap (In PLN)

44.55 Million

Revenue (In PLN)

9.83 Million

Net Income (In PLN)

28.94 Million

Avg. Volume

3541.00

Currency
PLN
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
3.98-9.18
PE
-
EPS
-
Beta Value
0.574
ISIN
PLPHRMN00011
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Biotechnology
CEO
Mr. Konrad Palka
Employee Count
-
Website
https://www.pharmena.eu
Ipo Date
2008-08-01
Details
Pharmena S.A., a biotechnology company, manufactures and sells active ingredients in various areas of medicines in Poland and internationally. The company offers dermatological cosmetics, including skin, hair, and nail care products, as well as dietary supplement for atherosclerosis prophylaxis. It offers its products under the Menavitin, Dermena, Allerco, and Thermi names. The company is developing 1-MNA, an anti-atherosclerosis drug which is under phase II clinical trial. Pharmena S.A. was founded in 2002 and is based in Lódz, Poland. Pharmena S.A. is a subsidiary of Pelion S.A.